Download PDF
Aktuelle Rheumatologie 2018; 43(02): 126-134
DOI: 10.1055/s-0043-121984
Übersichtsarbeit
© Georg Thieme Verlag KG Stuttgart · New York

Virusassoziierte Arthritiden – Globalisierung von Überträgern und Erregern

Virus-Associated Arthritis: Globalisation of Vectors and Viruses
Armin Ensser
1   Virologisches Institut, Universitatsklinikum Erlangen, Erlangen
› Author Affiliations
Further Information

Publication History

Publication Date:
22 February 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Aufgrund veränderter Verbreitungsgebiete der Vektoren muss inzwischen auch in Süd- und Mitteleuropa mit dem gelegentlichen Auftreten von lokal erworbenen Infektionen und kleineren Ausbrüchen „tropischer“ Viren gerechnet werden. Die Mehrzahl der Fälle ist jedoch Reiserückkehrern aus Epidemie- und Endemiegebieten zuzuordnen. Virusassoziierte Arthritis ist besonders kennzeichnend für die akute Infektion mit dem Chikungunya-Virus. Differentialdiagnostisch sind eine Reihe weiterer Erreger und Frühformen der rheumatoiden Arthritis und anderer Autoimmunerkrankungen abzugrenzen.

Abstract

Although the majority of cases can still be attributed to travellers returning from epidemic and endemic areas, changes in the distribution of insect vectors will increase the frequency of locally acquired infections and minor outbreaks of “tropical” viruses in Southern and Central Europe. Virus-associated arthritis is a characteristic feature of an acute infection with the Chikungunya virus. A number of other tropical and endemic pathogens as well as early forms of rheumatoid arthritis and other autoimmune diseases should be included in the differential-diagnostic evaluation.

Schlüsselwörter

Arthiritis - Togaviridae - Flaviviridae - Chikungunya-Virus

Key words

viral - arthritis - diagnosis - Chikungunya virus
 

  • Literatur

  • 1 Hartung K, Ehrfeld H, Gerritzen A. et al. Laboratory diagnosis of rheumatic diseases. Part 3: arthritides caused by infection. Z Rheumatol 2007; 66: 395-415
    CrossrefPubMedGoogle Scholar
  • 2 Teo TH, Chan YH, Lee WW. et al. Fingolimod treatment abrogates chikungunya virus-induced arthralgia. Sci Transl Med 2017; 9
    PubMedGoogle Scholar
  • 3 Chen W, Foo SS, Rulli NE. et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. Proc Natl Acad Sci U S A 2014; 111: 6040-6045
    CrossrefPubMedGoogle Scholar
  • 4 Assuncao-Miranda I, Cruz-Oliveira C, Da Poian AT. Molecular mechanisms involved in the pathogenesis of alphavirus-induced arthritis. Biomed Res Int 2013; 2013: 973516
    PubMedGoogle Scholar
  • 5 Roiz D, Bousses P, Simard F. et al. Autochthonous Chikungunya Transmission and Extreme Climate Events in Southern France. PLoS Negl Trop Dis 2015; 9: e0003854
    CrossrefPubMedGoogle Scholar
  • 6 Enserink M. Epidemiology. Tropical disease follows mosquitoes to Europe. Science 2007; 317: 1485
    PubMedGoogle Scholar
  • 7 Jalava K, Sane J, Ollgren J. et al. Climatic, ecological and socioeconomic factors as predictors of Sindbis virus infections in Finland. Epidemiol Infect 2013; 141: 1857-1866
    CrossrefPubMedGoogle Scholar
  • 8 Mejia CR, Lopez-Velez R. Tropical arthritogenic alphaviruses. Reumatol Clin 2017; DOI: 10.1016/j.reuma.2017.01.006.
    CrossrefPubMedGoogle Scholar
  • 9 Lwande OW, Obanda V, Bucht G. et al. Global emergence of Alphaviruses that cause arthritis in humans. Infect Ecol Epidemiol 2015; 5: 29853
    PubMedGoogle Scholar
  • 10 Grandadam M, Caro V, Plumet S. et al. Chikungunya virus, southeastern France. Emerg Infect Dis 2011; 17: 910-913
    CrossrefPubMedGoogle Scholar
  • 11 Delisle E, Rousseau C, Broche B et al. Chikungunya outbreak in Montpellier, France, September to October 2014. Euro Surveill 2015; 20: pii: 21108
    PubMed
  • 12 Rezza G, Nicoletti L, Angelini R. et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370: 1840-1846
    CrossrefPubMedGoogle Scholar
  • 13 Burt FJ, Chen W, Miner JJ. et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis 2017; 17: e107-e117
    CrossrefPubMedGoogle Scholar
  • 14 Faria NR, Azevedo Rdo S, Kraemer MU. et al. Zika virus in the Americas: Early epidemiological and genetic findings. Science 2016; 352: 345-349
    CrossrefPubMedGoogle Scholar
  • 15 Sousa CA, Clairouin M, Seixas G. et al. Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira. Portugal: preliminary report. Euro Surveill; 2012: 17 : pii: 20333
    Google Scholar
  • 16 Franco L, Pagan I, Serre Del Cor N. et al. Molecular epidemiology suggests Venezuela as the origin of the dengue outbreak in Madeira, Portugal in 2012–2013. Clin Microbiol Infect 2015; 21: 713 e715-718
    PubMedGoogle Scholar
  • 17 Simmons CP, Farrar JJ. Nguyen v V et al. Dengue. N Engl J Med 2012; 366: 1423-1432
    CrossrefPubMedGoogle Scholar
  • 18 Bhatt S, Gething PW, Brady OJ. et al. The global distribution and burden of dengue. Nature 2013; 496: 504-507
    CrossrefPubMedGoogle Scholar
  • 19 World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. In, New Edition Geneva: 2009
    Google Scholar
  • 20 Simpson DI. Zika Virus Infection in Man. Trans R Soc Trop Med Hyg 1964; 58: 335-338
    CrossrefPubMedGoogle Scholar
  • 21 Victora CG, Schuler-Faccini L, Matijasevich A. et al. Microcephaly in Brazil: how to interpret reported numbers?. Lancet 2016; 387: 621-624
    CrossrefPubMedGoogle Scholar
  • 22 Musso D, Lanteri MC. Emergence of Zika virus: where does it come from and where is it going to?. Lancet Infect Dis 2017; 17: 255
    PubMedGoogle Scholar
  • 23 Vouga M, Musso D, Schaub B. et al. Zika virus: are we going too far?. Lancet 2017; 389: 151
    PubMedGoogle Scholar
  • 24 Smith DW, Mackenzie J. Zika virus and Guillain-Barre syndrome: another viral cause to add to the list. Lancet 2016; 387: 1486-1488
    CrossrefPubMedGoogle Scholar
  • 25 Parra B, Lizarazo J, Jimenez-Arango JA. et al. Guillain-Barre Syndrome Associated with Zika Virus Infection in Colombia. N Engl J Med 2016; 375: 1513-1523
    CrossrefPubMedGoogle Scholar
  • 26 Tanay A. Chikungunya virus and autoimmunity. Curr Opin Rheumatol 2017; 29: 389-393
    CrossrefPubMedGoogle Scholar
  • 27 Bouquillard E, Fianu A, Bangil M. et al. Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study). Joint Bone Spine 2017; DOI: 10.1016/j.jbspin.2017.01.014.
    CrossrefPubMedGoogle Scholar
  • 28 Schilte C, Staikowsky F, Couderc T. et al. Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 2013; 7: e2137
    CrossrefPubMedGoogle Scholar
  • 29 Cherabuddi K, Iovine NM, Shah K. et al. Zika and Chikungunya virus co-infection in a traveller returning from Colombia, 2016: virus isolation and genetic analysis. JMM Case Rep 2016; 3: e005072
    PubMedGoogle Scholar
  • 30 Furuya-Kanamori L, Liang S, Milinovich G. et al. Co-distribution and co-infection of chikungunya and dengue viruses. BMC Infect Dis 2016; 16: 84
    CrossrefPubMedGoogle Scholar
  • 31 Pabbaraju K, Wong S, Gill K. et al. Simultaneous detection of Zika, Chikungunya and Dengue viruses by a multiplex real-time RT-PCR assay. J Clin Virol 2016; 83: 66-71
    CrossrefPubMedGoogle Scholar
  • 32 Holland R, Barnsley L, Barnsley L. Viral arthritis. Aust Fam Physician 2013; 42: 770-773
    PubMedGoogle Scholar
  • 33 Miner JJ, Aw Yeang HX, Fox JM. et al. Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol 2015; 67: 1214-1220
    CrossrefPubMedGoogle Scholar
  • 34 Schmidt-Chanasit J, Tenner-Racz K, Poppert D. et al. Fatal dengue hemorrhagic fever imported into Germany. Infection 2012; 40: 441-443
    CrossrefPubMedGoogle Scholar
  • 35 World Health O. Dengue vaccine: WHO position paper, July 2016 - recommendations. Vaccine 2017; 35: 1200-1201
    CrossrefPubMedGoogle Scholar
  • 36 Rouvinski A, Guardado-Calvo P, Barba-Spaeth G. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 2015; 520: 109-113
    CrossrefPubMedGoogle Scholar